Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines
- 1 December 1996
- Vol. 120 (6) , 944-947
- https://doi.org/10.1016/s0039-6060(96)80038-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Hypoxia-induced Transcriptional Activation and Increased mRNA Stability of Vascular Endothelial Growth Factor in C6 Glioma CellsJournal of Biological Chemistry, 1995
- Consequences of angiogenesis for tumor progression, metastasis and cancer therapyAnti-Cancer Drugs, 1995
- Tamoxifen inhibits growth, migration, and invasion of human follicular and papillary thyroid cancer cells in vitro and in vivoJournal of Clinical Endocrinology & Metabolism, 1995
- Thyrotropin Stimulates Invasion and Growth of Follicular Thyroid Cancer Cells via PKC- Rather Than PKA-ActivationBiochemical and Biophysical Research Communications, 1993
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues.Journal of Clinical Investigation, 1992
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989
- PAPILLARY THYROID CARCINOMAMedicine, 1977
- The endocrine dependency of certain thyroid cancers and the danger that hypothyroidism may stimulate their growthCancer, 1957